RBPJ and neoplasm: To explore the role of CSL in a breast tumor context, we targeted both CSL alleles by CRISPR/Cas9 genome editing in MDA-MB-231 cells (Figure 1A), a breast tumor cell line with active Notch signaling and which promotes tumor growth when transplanted in vivo (Holliday and Speirs, 2011, Jin et al., 2013).